INO:NASDAQ
Inovio Pharmaceuticals Inc
1,36 $
arrow_downward
-4,58%(-0,065) 1D
9 սեպ, 14:26:32 GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for INO...
Open
1,41 $
High
1,45 $
Low
1,34 $
Mkt. cap
140,10 մլն
Avg. vol.
5,67 մլն
Volume
1,97 մլն
52-wk high
2,82 $
52-wk low
0,57 $
EPS
-1,17 $
Beta
1,63
Shares outstanding
103,40 մլն
No. of employees
112
Open
1,41 $
High
1,45 $
Low
1,34 $
Mkt. cap
140,10 մլն
Avg. vol.
5,67 մլն
Volume
1,97 մլն
52-wk high
2,82 $
52-wk low
0,57 $
EPS
-1,17 $
Beta
1,63
Shares outstanding
103,40 մլն
No. of employees
112
News stories
From web sources and news partners
https://www.dars.gov.et/
·
3 ամիս առաջ
INO Q1 2026 Earnings: Narrower Loss Beats Estimates as Pipeline Progress Continues - Share Repurchase Impact
Profile
Inovio Pharmaceuticals, Inc. is an American biotechnology company focused on the discovery, development, and commercialization of synthetic DNA products for treating cancers and infectious diseases. In April 2020, Inovio was among some 100 companies, academic centers, or research organizations developing a vaccine candidate for treating people infected with COVID-19, with more than 170 total vaccine candidates in development. Wikipedia
About Inovio Pharmaceuticals Inc